Merrimack Pharmaceuticals is a pharmaceutical company based in Cambridge, Massachusetts, United States. They specialize in developing drugs for the treatment of cancer. Merrimack's first FDA-approved drug was approved in 2015; Onivyde, a liposome encapsulated version of irinotecan is used for treating pancreatic adenocarcinoma. It was approved for use in Europe the following year.

Property Value
dbo:abstract
  • Merrimack Pharmaceuticals is a pharmaceutical company based in Cambridge, Massachusetts, United States. They specialize in developing drugs for the treatment of cancer. Merrimack's first FDA-approved drug was approved in 2015; Onivyde, a liposome encapsulated version of irinotecan is used for treating pancreatic adenocarcinoma. It was approved for use in Europe the following year. (en)
dbo:numberOfEmployees
  • 426 (xsd:integer)
dbo:type
dbo:wikiPageEditLink
dbo:wikiPageExternalLink
dbo:wikiPageExtracted
  • 2020-01-08 13:49:22Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 53069051 (xsd:integer)
dbo:wikiPageLength
  • 4729 (xsd:integer)
dbo:wikiPageModified
  • 2020-01-08 13:49:20Z (xsd:date)
dbo:wikiPageOutDegree
  • 39 (xsd:integer)
dbo:wikiPageRevisionID
  • 934792017 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • Merrimack Pharmaceuticals is a pharmaceutical company based in Cambridge, Massachusetts, United States. They specialize in developing drugs for the treatment of cancer. Merrimack's first FDA-approved drug was approved in 2015; Onivyde, a liposome encapsulated version of irinotecan is used for treating pancreatic adenocarcinoma. It was approved for use in Europe the following year. (en)
rdfs:label
  • Merrimack Pharmaceuticals (en)
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Merrimack Pharmaceuticals (en)
owl:sameAs
is dbo:wikiPageDisambiguates of
is foaf:primaryTopic of